Legislation introduced in April 2017 requires all legal entities of 250 or more employees to publish their gender pay gap. The gender pay gap is the difference between the average earnings of men and women, expressed relative to men’s earnings. For example,Read More
At Concept Life Sciences we are proud to offer extensive biophysical assay expertise which complements our existing capabilities in pharmaceutical discovery and development.
As a result of our ongoing work and extensive research, we are pleased to announce that our Head of Bioassay Development and Screening,
Dr Tim Calvert joins as Vice President of Business Development, Integrated Discovery Services, Europe.
Dr Michael Donaldson joins as Principal Scientist, Dermal Services.
Appointments support continued expansion into the Global market.
Manchester, UK, 27 February 2018: Concept Life Sciences (Concept), the integrated drug discovery,Read More
Successful MHRA inspection at Dundee site confirms GLP accreditation for in vitro safety studies and bioanalysis
GLP ensures quality and integrity in non-clinical laboratory studies and gives confidence in safety assessment
Manchester and Dundee, UK, 8th February 2018: Concept Life Sciences (“Concept”),Read More
Research by Dr Hassan Harb (Lead Chemist) at Concept Life Sciences (Alderley Park) and Luke Whitaker (RSC Enterprise Plus funded industrial placement student) in collaboration with Dr Alexander Pulis (Lecturer in Organic Chemistry) at the University of Manchester has recently been published in Chemical Communications.Read More
Ahead of #WorldCancerDay on Sunday 4th February, we are delighted announce our support to the Alderley Park and Bionow event ‘Accelerating Cancer Drug Development – From Target to Patients’.
Taking Place on 27th February at Alderley Park Conference Centre, our Group Leader Thomas Pesnot will be giving a talk titled ‘Tailoring Screening Libraries for Neuro-Oncology using Multiparameter Optimisation’.
Acquisition increases Concept’s global reach and supports growth strategy
Synergies with Spectris’ molecular testing and analysis expertise will provide customers with
access to a broader range of services
Manchester and Egham, UK, 26 January 2018: Concept Life Sciences (‘Concept’),Read More
Concept Life Sciences (“Concept”), the integrated drug discovery, development and analytical services company, and Alderley Analytical, the GLP/GCP compliant, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.
Under the terms of the agreement,
Key leadership appointments support integration of the group and expansion in the US market
Manchester, UK, 11th January 2018: Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has appointed Helen McKeever as Programme Manager for the Group,
Company ends 2017 with revenues in excess of $65m/£49m
Plans for profitable growth of over 30% in 2018
Dr Andrew Scott appointed Head of Bioassay Development and Screening
Magalie Ferbach joins as Business Development Director for Southern and Central Europe
£250k investment doubles capacity across many service areas
Manchester, UK, 28 November 2017: Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has invested £250k in new equipment at its East Kilbride analytical services site.
The long awaited vote on the authorisation of glyphosate for another term has been cast amongst EU member states and was inconclusive. On the 9th of November, 14 EU member states voted in favour or renewing the authorisation including UK, however,Read More
09 November 2017: Aquila BioMedical Ltd., an innovative preclinical contract research organisation (CRO) now part of Concept Life Sciences group, has secured an extended agreement with UK-based biotech firm Macrophage Pharma Ltd. to support its preclinical immuno-oncology programmes.
Macrophage Pharma’s Esterase Sensitive Motif™ (ESM™) technology enables delivery of novel,
Acquisition adds immuno-oncology capability to broaden Concept’s range of integrated drug discovery and development services
Manchester, UK, 30 October 2017: Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has acquired Aquila BioMedical (Aquila),
Appointment supports continued expansion of the group and completes leadership team
Manchester, UK, 24 October 2017: Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has appointed Philip Payne as Chief Commercial Officer,
Concept Life Sciences are attending the upcoming CPhI Worldwide event, taking place in Frankfurt, Germany between October 24th – 26th. We will be running a competition to win an Apple Watch.
HOW TO ENTER:
Attend CPhI Worldwide
Arrange a meeting with a Concept Life Sciences representative (Will Bromley,
Appointment supports growth of the Company and expansion of expertise in integrated drug discovery and development
Manchester, UK, 11 October 2017: Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has appointed Marc Princivalle as Group Head of Toxicology,
New state-of-the-art facilities increase scientific capacity by over 30%
Manchester, UK, 12 September 2017: Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has expanded into new state-of-the-art facilities at Alderley Park in Cheshire,
If you are attending ACS Chemistry for Life then you could be in with a chance of winning an Apple Watch.
To enter the Competition you must be attending the event (ACS) and schedule a meeting with our Director of Business Development for North America Heidi Schulze.
Concept Life Sciences a knowledge-based, science-led business providing a wide range of innovative and integrated solutions within the pharmaceutical, biotechnology, food, environmental, agrochemical, biocides, chemical and consumer sectors, today announces the appointment of John Handley as Chief Operating Officer.
In his role,
Concept Life Sciences has added polycyclic aromatic hydrocarbons (PAH) analysis in edible oils to its range of ISO 17025 accredited services.
PAHs have been linked to a number of health issues including various forms of cancer, therefore, the food and allied industries have a responsibility to ensure product safety.
Fipronil is an insecticide commonly used in veterinary products to treat fleas, mites and marks. However, it is banned from the use in animals that will enter the food chain such as chickens.
Recent unauthorised use of products containing Fipronil has led to its residues to be found in eggs that have entered the food chain in mainland Europe and in small numbers of eggs entering the UK market.
Concept Life Sciences is pleased to announce the appointment of Jane Shackleton as Group Head of Quality Assurance. In her role Jane will be responsible for ensuring that the needs of both customers and certifying bodies & regulators are met and that a consistent approach to quality based processes is achieved across the group.Read More
Interested in Developing a Career in Analytical Sciences? Meet the Science behind the Concept at our Analytical Services Division Careers Open Day
Following on from the success of our first careers open day, Concept Life Sciences Analytical Services Division host another open day on Thursday 21st September.
Drum Roll Please……! The winner of our Summer Competition is Ed Palairet from Soil Association. Congratulations Ed – you were chosen yesterday at random from our list of newsletter subscribers. To claim your £100 Amazon Vouchers please contact email@example.com. Thank you to everyone who entered the summer competition and subscribed to our newsletter.Read More
A paper, entitled “Mode of action and human relevance of THF-induced mouse liver tumours” published in Toxicology Letters1 presents research and results demonstrating that THF, a non-genotoxic mouse liver carcinogen that induces liver tumours in mice, likely does so via Constitutive Androstane Receptor (CAR) activation,Read More
Dr Andrew Clifton joins Concept Life Sciences as Head of Bioassay Development and Screening Technologies. Concept Life Sciences offers tailored preclinical services including integrated drug discovery programs. Dr Clifton strengthens the existing industry team at Concept and will be responsible for providing assay development and screening capabilities to support preclinical drug discovery projects from hit finding through to candidate selection.Read More
To celebrate the launch of our new website, we are pleased to announce our exciting summer competition!
For your chance to win a £100 Amazon Gift Card*, all you have to do is subscribe to the Concept Life Sciences newsletter by 12pm,
Interested in Developing a Career in Analytical Sciences? Meet the Science behind the Concept at our Analytical Services Division Careers Open Day
Concept Life Sciences Analytical Services Division are hosting an open day on Tuesday 18th July. Taking place at our Manchester site the open day aims to give you the opportunity to meet the team,
Dr Graeme Clark PHD has joined Concept Life Sciences Dundee as Director of Analytical Services and DMPK. Concept Life Sciences offers tailored preclinical services in areas including investigative and mechanistic toxicology, exploratory and discovery toxicology, PK and metabolism and dermal absorption,Read More
We are pleased and excited to announce the launch of our new Concept Life Sciences new website.
The improved site showcases the integration and broadening of our group services offering and reflects our two new divisional structures; Integrated Discovery & Development Services and Analytical Services.
Concept Life Sciences has further expanded its analytical testing capabilities by making significant investment into Micro-Chamber and Thermal Extraction facilities , used to sample VOCs or SVOCs emitted from products and materials. The investment has been made to cope with the growing demand from both new and existing clients who insist on speedy,Read More
The Concept Life Sciences Group, has further strengthened its senior team with the appointment of Colin Hardie as VP Business Development Preclinical Services , Dave Brown as VP Operations – UK and Darryl Chapman VP Sales and Marketing. The Group recently announced a multimillion pound investment drive,Read More
Concept Life Sciences, the group created from the merger of Scientific Analysis Laboratories, Agenda1, Peakdale Molecular, CXR Biosciences and REC, has launched two REACH testing services.
The first testing service is Substance Sameness and Identification Testing for the 2018 REACH Registration deadline.
Concept Life Sciences – Analytical Services are hosting several training courses across the UK. Continuing on from the success of 2016, course dates have now been booked for the Microbiology and Pesticides training courses in Cambridge.
INTRODUCTION TO MICROBIOLOGY TESTING IN FOOD
Price includes refreshments,
We are pleased to present the next instalment of our live webinar series, titled Drug Discovery Beyond the Traditional: New Approaches to Biotherapeutics. The free webinar aims to offer a Medicinal Chemists guide to the nuances of Biotherapeutics and Bioconjugation.
DATE: Wednesday April 12th 2017 | TIME: 4pm GMT,
Research carried out at Concept Life Sciences (formerly CXR Biosciences), the investigative & exploratory toxicology company, is being presented in two posters at the upcoming Society Of Toxicology (SOT) 2017 annual meeting in Baltimore on 12th – 16th March. This mechanistic research has been performed in partnership with Endura SpA,Read More
Paul Doyle has taken up the role of Chief Scientific Officer at Concept Life Sciences. The news of his new role coincides with the news that the Concept Life Sciences Group has embarked upon a multi-million pound investment drive, comprising a comprehensive expansion and rebranding programme,Read More
Concept Life Sciences Group, the business formed in 2014 to break into the international Discovery & Development and Analytical markets, has announced its intention to significantly increase its investment in laboratory capacity and scientific staff in a Multi Million Pound Expansion Programme and Rebranding.Read More
Congratulations to TWO teams at Peakdale Molecular who have been selected to compete in the final of the 4th National SCI/ RSC Retrosynthesis Competition 2017.
From over 100 entries both the ‘Peakdale Chapel Team’ and ‘The Vinylagous Seven’ (based at Peakdale’s Sandwich site),
Scientific Analysis Laboratories (SAL) are starting the year off by hosting several training courses across the UK. Continuing on from the success of 2016, course dates have now been booked for the Microbiology and Pesticides training courses in Cambridge – with a new,Read More
Scientific Analysis Laboratories (SAL) is now delivering specific aerosol and e-cigarette emission testing throughout the UK and worldwide. As one of the largest laboratories in Europe, SAL has pioneered and developed robust methods for device operation and sampling of such emissions for parameter such as,Read More
Knowledge based, science led business, Concept Life Sciences, has further strengthened its team with the appointment of Tony Johnson as Group Business Development Executive. Tony, who joined the company on 14th November, is based at the group’s new science hub which is located on the Listerhills Science Park in Bradford.Read More
Concept Life Sciences has unveiled a new building on the Listerhills Science Park in Bradford to accommodate its growing workforce. The current facility which is home to Agenda1 (part of the Concept Life Sciences group), comprises both laboratories and offices, and due to increasing client demand has reached full capacity.Read More
Peakdale Molecular Limited, a UK-based provider of drug discovery services to the pharmaceutical and biotech industries and part of the Concept Life Sciences Group, has signed a collaboration agreement with Metrion Biosciences Limited, a specialist ion channel contract research organisation, to offer complete Integrated Drug Discovery Programmes to new and existing and new customers for ion channel targets.Read More
CXR Biosciences, part of the Concept Life Sciences Group, has been crowned winner of the ‘Science and Technology Business of the Year’ award at The Courier Business Awards for the second year running. The award was presented to the company on Saturday 29th October at an official awards ceremony which was held at The Apex City Quay Hotel in Dundee.Read More
Peakdale Molecular Limited, a UK-based provider of drug discovery services to the pharmaceutical and biotech industries and part of the Concept Life Sciences Group, recently held its fourth ‘Synthesis in Drug Discovery and Development’ symposium in Liverpool which explored the complex areas regarding drug discovery and development.
Congratulations to Sir Fraser Stoddart and the other recent chemistry Nobel laureates for their research with molecular machines!
It is always good to get some recognition for a job well done and here at Concept Life Sciences one of our chemists can claim a close involvement with the work.
After a very successful year so far at SAL’s Cambridge branch, our training courses are now coming to an end for 2016.
Two of our courses, ‘Introduction to Microbiology Testing in Food’ and ‘Introduction to Pesticide Residue Analysis and Legislation’ have proven to be extremely popular this year –
CXR Biosciences, part of the Concept Life Sciences Group, held its second Scientific Advisory Board recently which focused on the mechanistic toxicology services required by the agrochemical, chemical, pharmaceutical and consumer products industries.
CXR brought together experienced investigative toxicologists from across the various target industries to debate industry needs and emerging trends and how CXR could utilise its specific experience in this space to maximise the opportunities.